Zerodol SP Tablet

• Pain relief

Zerodol SP Tablet can cause multiple side effects, most of which are mild to moderate and often temporary. Patients are advised to inform their healthcare provider immediately if symptoms stays for prolonged period of time.

• Nausea
• Vomiting
• Stomach pain
• Indigestion
• Heartburn
• Loss of appetite
• Diarrhea
• Dizziness
• Increased liver enzymes
• Drowsiness

• Doctor determines the exact dose and duration with Zerodol SP Tablet as per the overall health condition of the patient. This tablet should be taken with food or after food, but at the fix time every day to get effective results.
• Don't miss a dose or overdose on the medicine. Swallow it as a whole with a glass of water and do not crush, chew, or open it.​​
  

• Zerodol SP Tablet is a combination of medicine known as Aceclofenac (100mg), Paracetamol (325mg), and Serratiopeptidase (15mg). Paracetamol is an antipyretic (fever reducer), and Aceclofenac is a non-steroidal anti-inflammatory medicine (NSAID).
• They act by preventing the brain's production of certain chemical messengers that are responsible for fever and discomfort. An enzyme known as serratiopeptidase supports in healing by dissolving abnormal proteins at the site of inflammation.​​
  

• Manjula, S., & Krishna Kumar, M. (2025). Assessment of Pain Management Practices and Analgesic Prescription Patterns among Dental Practitioners in Indian Settings. South Asian Res J Oral Dent Sci, 7(1), 1-7. https://www.researchgate.net/publication/389904503_Assessment_of_Pain_Management_Practices_and_Analgesic_Prescription_Patterns_among_Dental_Practitioners_in_Indian_Settings
• Mohan, N. Dental Intervention Procedures: Challenges, Management and Role of Aceclofenac, Paracetamol and Serratiopeptidase Based Combination Treatment.
• Reddy, A. R., Rajamani, K., Mounika, A., & Reddy, G. S. (2014). Development and validation of RP-HPLC method for simultaneous estimation of paracetamol, aceclofenac and serratiopeptidase in combined tablet dosage form.https://www.researchgate.net/publication/319964786_DEVELOPMENT_AND_VALIDATION_OF_RP-HPLC_METHOD_FOR_SIMULTANEOUS_ESTIMATION_OF_PARACETAMOL_ACECLOFENAC_AND_SERRATIOPEPTIDASE_IN_COMBINED_TABLET_DOSAGE_FORM
• Veena, R. S., Sudha, P. D., Ranganath, M. K., Baskaran, V., & Kumar, P. S. (2025). SIMULTANEOUS DETERMINATION OF ACECLOFENAC, PARACETAMOL, SERRATIOPEPTIDASE IN TABLET DOSAGE FORM BY A NOVEL STABILITY INDICATING RP-UPLC METHOD. Biochemical & Cellular Archives, 25(1).
• Baig, A. S., Mangat, P., Bajpai, G., Chandel, B., Biswas, M., Baig, I., & Begum, H. (2025). Effect of Occlusal Reduction on Post-operative Pain in Diabetic and Non-diabetic Patients With Symptomatic Apical Periodontitis in a Single Visit: An In Vivo Study. Cureus, 17(10).
• Parulekar, V. V., & Badar, V. A. (2020). Observing drug utilization trends of analgesics in indoor surgical patients in tertiary care teaching hospital. Asian J Pharm Clin Res, 13(5), 47-50.